Table 2.
All |
Age at MBC |
P value between age groups |
|||||||
---|---|---|---|---|---|---|---|---|---|
<40 years |
[40–60] years |
>60 years |
|||||||
N | % | N | % | N | % | N | % | ||
Time to first metastasis | <0.0001 | ||||||||
De novo (< 3 months) | 4058 | 28.2% | 339 | 31.5% | 1849 | 28.7% | 1870 | 27.1% | |
[3–24[ months | 2284 | 15.9% | 308 | 28.6% | 1114 | 17.3% | 862 | 12.5% | |
>= 24 months | 8035 | 55.8% | 429 | 39.8% | 3461 | 53.8% | 4145 | 60.2% | |
NA | 26 | 0.2% | 1 | 0.1% | 12 | 0.2% | 13 | 0.2% | |
Number of metastatic sites | 0.02 | ||||||||
One site | 7976 | 55.4% | 572 | 53.1% | 3493 | 54.3% | 3911 | 56.8% | |
Two sites | 3473 | 24.1% | 267 | 24.8% | 1586 | 24.6% | 1620 | 23.5% | |
Three or more sites | 2954 | 20.5% | 238 | 22.1% | 1357 | 21.1% | 1359 | 19.7% | |
Type of metastasis | <0.0001 | ||||||||
Bone only | 8145 | 65.3% | 562 | 52.2% | 3587 | 55.7% | 3996 | 58.0% | |
Visceral | 4584 | 15.6% | 391 | 36.3% | 2140 | 33.3% | 2053 | 29.8% | |
Other (neither visceral nor bone) | 1674 | 19.1% | 124 | 11.5% | 709 | 11.0% | 841 | 12.2% | |
Tumor subtype | <0.0001 | ||||||||
HoR + HER2- | 9398 | 15.6% | 519 | 48.2% | 3934 | 61.1% | 4945 | 71.8% | |
HoR-HER2- | 2247 | 19.1% | 272 | 25.3% | 1138 | 17.7% | 837 | 12.1% | |
HER2+ | 2758 | 65.3% | 286 | 26.6% | 1364 | 21.2% | 1108 | 16.1% | |
De novo MBC –treatment of primary tumor <1y from diagnosis | |||||||||
Breast surgery | 691 | 17.0% | 90 | 26.5% | 374 | 20.5% | 227 | 12.1% | 0.001 |
Loco-regional RT | 1333 | 32.8% | 173 | 51.0% | 705 | 38.1% | 455 | 24.3% | <0.0001 |